Gynecological - Emma Fields, MD
March 27, 2018
Case Summaries:
Discuss CB-CHOP (by Mary Dean in Applied Radiation Ooncology Dec 2017) as a simple way to evaluate a plan.
Goal is to be systematic in the evaluation so that you don’t miss things.
http://appliedradiationoncology.com/articles/cb-chop-a-simple-acronym-for-evaluating-a-radiation-treatment-plan
Contours
Beam Arrangement/fields
Coverage
Heterogeneity/Hot and cold spots
Oars
Prescription
Case 1: Intact Cervix: 4 field and IMRT comparison
64 year old with RLQ pain for 1 year and 6 weeks of post-menopausal bleeding found to have a 6 cm mass in the cervix, FIGO IIB, left PM involvement, SCC of the cervix.
Contours: UteroCervix – entire uterus is included in CTV
For IMRT have to think more about PTV margins – at the uterus is a mobile structure
Beams: With 4 field box need to make sure entire CTV is included, cover entire sacrum for the uterosacral ligament and pre-sacral nodes.
Coverage:
Tools to use:
Qualitative: Isodose lines
Quantitative: Dose statistics + DVH
DVHs: Limitations – no spatial information (where hot/cold spots are)
Discuss PTV Coverage – difference in conformity and heterogeneity with 3DCRT vs. IMRT
Heterogeneity: Hot spots + Cold spots
- Volume
- Magnitude
- Location
For IMRT remember:
If priority is conformity – accept increased inhomogeneity
If priority is homogeneity – accept decreased conformity
Questions to think about:
- What level of coverage is acceptable?
- What amount of hot spot is acceptable?
- What are your goals? What can you compromise on/what is not flexible?
OARs: Parallel vs. Serial structures, make sure constraints are relevant to the lower doses used in gyn planning (as opposed to prostate)
Prescription: Usually 45Gy to the whole pelvis. Need to consider central dose when planning to add brachytherapy. Doses can be tracked in the ABS brachytherapy worksheet.
https://www.americanbrachytherapy.org/guidelines/index.cfm
Case 2: Uterine Postop: IMRT
63 year old with FIGO grade 1 stage IB endometrioid adenocarcinom s/p TAHBSO with deep invasion of the myometrium and LVSI.
Contours: ITV for vaginal cuff: how it is created, full bladder scan used for treatment planning and daily treatment. Patients need bladder filling instructions to make consistent.
Beams: Assess beam angles. How can you tell if a plan is with static IMRT vs. Arcs. Assess beam entrance paths and ensure not through OARs.
Coverage: Similar to prior case.
Heterogeneity: Similar to prior cases.
OARs: Great reference for constraints RTOG 1203. Consider adding bone marrow if giving concurrent chemotherapy.
Prescription: Usually 45-50.4Gy
Discussion: IMRT may not be feasible in women who cannot hold full bladder, are morbidly obese, or need to start treatment quickly.
Case 3: Uterine postop: 4 field
83 year old with FIGO IIIA grade 2 endometriod adenocarcinoma s/p TAH BSO on RTOG 1203 and received 45 Gy in 25 fractions.
CB-CHOP
Contours: splitting sacrum on lateral field.
In post op setting with no uterus, bladder filling becomes even more important as bowel fills the space.
OARs: Bladder and rectum get the entire dose but can adjust this and use constraints with IMRT per RTOG 1203 constraints (as above).
Brachytherapy:
- T&O
60 year old with vaginal discharge with FIGO IIB) left PM involvement SCC of the cervix.- looking at placement with xray or fluoroscopy
- -Point A and B
- Dosimetry and coverage
- Benefits and pitfalls of inverse planning
- D2cc and adding doses with EBRT on excel spreadsheet
- looking at placement with xray or fluoroscopy
- Cylinder
65 year old with FIGO grade 1 stage IB (10/12mm MMI with no LVSI) endometriod adenocarcinoma s/p TAH-BSO and SLN.- Dosimetry, prescribing to 5mm depth vs. surface
- Coverage and constraints
- Syed Template
81 year old with a history of hysterectomy who had 2-3 months of vagina discharge and bleeding found to have SCC of the vagina involving the paravaginal extension without side wall extension, FIGO II.- Discussion of syed template and when to use
- Show MRI for pre plan and what to cover